Strengthening the Financial Base through a Capital Increase by Third-Party Allotment
First written in FY2016. 25 of 28 entries say "Advanced", first in FY2018-Q2. Latest entry: FY2026.
11 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The third-party allotment capital increase pursuant to a resolution of the Board of Directors meeting held on 24 December 2025 increased share capital and the capital reserve by ¥299 million each.」
Under the third-party allotment capital increase, 19,354,800 shares were issued on 13 January 2026, strengthening the capital base by a total of ¥599 million through cash contributions and debt-equity swaps. - 2026-05-13AdvancedEarnings
「At a board meeting held on 24 December 2025, the company resolved to issue new shares through a third-party allotment, and payment was completed on 13 January 2026. As a result, stated capital increased by ¥299 million and the capital surplus increased by ¥299 million. Of the total issue proceeds, ¥299 million was allocated through a cash contribution, while the remaining ¥299 million was allocated through an in-kind contribution of assets, namely a debt-to-equity swap.」
Payment for the third-party allotment of new shares was completed, strengthening the company’s capital through a cash contribution and a debt-to-equity swap. - FY2025AdvancedAnnual report
「With respect to the Series 16 Stock Acquisition Rights, 160,000 of the share acquisition rights with exercise price adjustment provisions attached to bonds, etc. were exercised during the period, 16,000,000 shares were delivered, and ¥257 million was raised.」
Exercise of the Series 16 Stock Acquisition Rights progressed, raising ¥257 million during the year. Cumulative funds raised reached ¥607 million, and all of the Stock Acquisition Rights had been exercised by the end of the year. - FY2025-H1AdvancedAnnual report
「During the interim consolidated accounting period, the exercise of Series 16 Stock Acquisition Rights increased share capital and the capital reserve by ¥53.966 million each. At the end of the interim consolidated accounting period, share capital was ¥3,219.046 million and capital surplus was ¥2,537.128 million.」
The exercise of 68,666 Series 16 Stock Acquisition Rights increased share capital and the capital reserve by approximately ¥54 million each and raised ¥105 million. Cumulative funds raised reached ¥455 million. - FY2024AdvancedAnnual report
「The main factor behind the change was a ¥737 million increase in share capital and capital surplus resulting from the issuance of new shares and the exercise of Series 16 Stock Acquisition Rights pursuant to a resolution of the Board of Directors meeting held on 6 April 2023」
The issuance of new shares and exercise of Series 16 Stock Acquisition Rights increased share capital and capital surplus by a total of ¥737 million. The equity ratio also rose from 2.0% to 11.0%. - FY2024-Q3AdvancedAnnual report
「In addition, payment for the new shares issued by the Company pursuant to a resolution of the Board of Directors meeting held on 6 April 2023 was completed on 24 April 2023, raising ¥567 million. In addition, 96,000 Series 16 Stock Acquisition Rights were exercised, raising ¥167 million.」
¥567 million was raised through payment for the new shares and ¥167 million through the exercise of the Series 16 Stock Acquisition Rights, advancing the capital strengthening. The equity ratio also rose from 2.0% to 11.1%. - FY2024-Q2AdvancedAnnual report
「In addition, payment for the new shares issued by the Company pursuant to a resolution of the Board of Directors meeting held on 6 April 2023 was completed on 24 April 2023, raising ¥567 million. In addition, 68,470 Series 16 Stock Acquisition Rights were exercised, raising ¥123 million.」
¥567 million was raised through payment for the new shares and ¥123 million through the exercise of 68,470 Series 16 Stock Acquisition Rights, advancing the capital strengthening. - FY2024-Q1AdvancedAnnual report
「Payment for the new shares issued by the company based on a resolution of the Board of Directors held on 6 April 2023 was completed on 24 April 2023, raising ¥567 million. In addition, the exercise of 43,470 Series 16 Stock Acquisition Rights raised ¥78 million.」
¥567 million was raised upon completion of the payment for the new shares, and ¥78 million through the exercise of 43,470 Series 16 Stock Acquisition Rights, advancing the capital strengthening. - FY2023AdvancedAnnual report
「The main factors behind the increase were a ¥1.009 billion increase in share capital and capital surplus through the issuance of new shares by DES based on resolutions of the Board of Directors held on 3 June 2022 and 10 March 2023, and a ¥173 million increase through the exercise of 94,000 Series 16 Stock Acquisition Rights.」
The annual results show ¥1.009 billion in capital strengthening through the DES and ¥173 million in proceeds from the exercise of 94,000 Series 16 Stock Acquisition Rights. - FY2023-Q3AdvancedAnnual report
「During the third quarter, 25,000 of the relevant convertible bonds with stock acquisition rights subject to exercise-price adjustment were exercised, 2,500,000 shares were delivered, and ¥44 million was raised, bringing cumulative proceeds to ¥182 million.」
With respect to Series 16 Stock Acquisition Rights, 25,000 rights were exercised during the third quarter, raising ¥44 million and bringing cumulative proceeds to ¥182 million. - FY2023-Q2AdvancedAnnual report
「During the six-month period ended the second quarter, 69,000 Series 16 Stock Acquisition Rights issued by the company based on a resolution of the Board of Directors held on 8 October 2021 were exercised, raising ¥128 million.」
During the six-month period ended the second quarter, 69,000 Series 16 Stock Acquisition Rights were exercised, raising ¥128 million. Capital strengthening progressed in conjunction with the increase in share capital and the capital reserve through the DES. - FY2023-Q1AdvancedAnnual report
「The main factors behind the increase were an ¥809 million increase in share capital and capital surplus through the issuance of new shares by DES based on a resolution of the Board of Directors held on 3 June 2022, and an ¥85 million increase in share capital and capital surplus through the exercise of 44,000 Series 16 Stock Acquisition Rights on 29 June 2022.」
The DES involving the representative director increased share capital and capital surplus by ¥809 million in total, while the exercise of 44,000 Series 16 Stock Acquisition Rights further advanced capital strengthening. - FY2022AdvancedAnnual report
「At a meeting of the Board of Directors held on 3 June 2022, the company resolved to issue new shares to its representative director, Kiyokawa Hiroshi (清川 浩志), by private placement through a debt-to-equity swap (DES). Payment was completed on 20 June 2022.」
By the filing date, a DES involving 36,800,000 shares and total proceeds of ¥809.6 million had been completed through a private placement to the representative director, advancing capital strengthening. - FY2022-Q3AdvancedAnnual report
「During the third quarter, 5,000 of the relevant convertible bonds with stock acquisition rights subject to exercise-price adjustment were exercised, 500,000 shares were delivered, and ¥9 million was raised, bringing cumulative proceeds to ¥9 million.」
With respect to Series 16 Stock Acquisition Rights, 5,000 rights were exercised, 500,000 shares were delivered, and ¥9 million was raised. - FY2022-Q2AdvancedAnnual report
「At a meeting of the Board of Directors held on 8 October 2021, the company resolved to issue Series 16 Stock Acquisition Rights by private placement, and payment in full of the issue price of these Stock Acquisition Rights was completed on 25 October 2021.」
The company resolved to issue Series 16 Stock Acquisition Rights to fund required working capital and future growth strategies, and payment of the total issue price of ¥12.07 million was completed. If all the rights are exercised, the proceeds are expected to be approximately ¥708 million. - FY2021AdvancedAnnual report
「During the consolidated fiscal year, all remaining Series 15 Stock Acquisition Rights were exercised, raising total proceeds of ¥325 million. In addition, on 12 January 2021, the company raised total proceeds of ¥699 million through a private placement and new borrowings to acquire income-generating properties for a new business.」
The exercise of all remaining Series 15 Stock Acquisition Rights raised ¥325 million, while the private placement and new borrowings to acquire income-generating properties raised a further ¥699 million in total. - FY2021-Q3AdvancedAnnual report
「During the third quarter, 20,535 of the relevant convertible bonds with stock acquisition rights subject to exercise-price adjustment were exercised, 2,053,500 shares were delivered, and ¥50 million was raised, bringing cumulative proceeds to ¥365 million.」
The exercise of Series 15 Stock Acquisition Rights during the third quarter raised ¥50 million, bringing cumulative proceeds to ¥365 million. - FY2021-Q2AdvancedAnnual report
「The exercise of Series 15 Stock Acquisition Rights increased share capital and the capital reserve by ¥139.221 million each. At the end of the second quarter, share capital was ¥2,022.878 million and capital surplus was ¥1,340.960 million.」
The exercise of Series 15 Stock Acquisition Rights increased share capital and the capital reserve by ¥139.221 million each during the six-month period ended the second quarter. During the quarterly accounting period, 91,500 rights were exercised, raising ¥227 million. - FY2021-Q1AdvancedAnnual report
「The exercise of Series 15 Stock Acquisition Rights increased share capital and the capital reserve by ¥23.793 million each. At the end of the first quarter, share capital was ¥1,907.450 million and capital surplus was ¥1,225.532 million.」
The exercise of Series 15 Stock Acquisition Rights increased share capital and the capital reserve by ¥23.793 million each during the quarter, advancing capital strengthening. - FY2020AdvancedAnnual report
「During the consolidated fiscal year, the company conducted a private placement and issued Series 14 Stock Acquisition Rights on 13 September 2019, and conducted another private placement and issued Series 15 Stock Acquisition Rights on 25 November 2019, raising total proceeds of ¥260 million. In addition, part of the Series 15 Stock Acquisition Rights was exercised during the consolidated fiscal year, raising an additional ¥40 million.」
Through Series 14 and Series 15 Stock Acquisition Rights and private placements, the company raised ¥260 million in total, plus an additional ¥40 million through the exercise of Series 15 Stock Acquisition Rights. - FY2020-Q3AdvancedAnnual report
「On 25 November 2019, the company received payment from Japan International Partners LLC for a private placement. As a result, during the nine-month period ended the third quarter, share capital and the capital reserve each increased by ¥24.999 million. The exercise of Series 15 Stock Acquisition Rights further increased share capital and the capital reserve by ¥901 thousand each. At the end of the third quarter, share capital was ¥1,863.944 million and capital surplus was ¥1,182.026 million.」
Capital strengthening progressed through the private placement by Japan International Partners LLC and the exercise of Series 15 Stock Acquisition Rights. - FY2020-Q2AdvancedAnnual report
「During the six-month period ended the second quarter, the company conducted a private placement and issued Series 14 Stock Acquisition Rights by private placement, raising total proceeds of ¥203 million.」
The company raised total proceeds of ¥203 million through a private placement and the issuance of Series 14 Stock Acquisition Rights. - FY2019-Q1AdvancedAnnual report
「In addition, as described under significant subsequent events, based on a resolution of the Board of Directors held on 6 July 2018, the company issued new shares and Series 11 through Series 13 Stock Acquisition Rights by private placement on 23 July 2018, raising total proceeds of ¥494 million.」
In addition to funding through the previous Stock Acquisition Rights, the company issued new shares and Series 11 through Series 13 Stock Acquisition Rights, completing a total capital raising of ¥494 million. - FY2018RestatedAnnual report
「The company issued Series 8 through Series 10 Stock Acquisition Rights by private placement on 23 October 2017. By 27 November 2017, approximately 33% of the total had been exercised, raising ¥381 million.」
The annual report also confirms the exercise of approximately 33% of the privately placed Stock Acquisition Rights and the raising of ¥381 million in total proceeds. - FY2018-Q3AdvancedAnnual report
「Based on a resolution of the Board of Directors held on 6 October 2017, the company issued Series 8 through Series 10 Stock Acquisition Rights by private placement on 23 October 2017. By 27 November 2017, approximately 33% of the total had been exercised, raising total proceeds of ¥381 million.」
Approximately 33% of the privately placed Stock Acquisition Rights had been exercised, representing progress toward raising total proceeds of ¥381 million. - FY2018-Q2AdvancedAnnual report
「At a meeting of the Board of Directors held on 6 October 2017, the company resolved to issue Series 8 through Series 10 Stock Acquisition Rights by way of a private placement. Payment of the total issue price was completed on 23 October 2017, and by 6 November 2017, the exercise of 52,000 Series 8 Stock Acquisition Rights, with total exercise proceeds of ¥278 million, had been completed.」
In addition to the previous private placement, progress was made through the resolution to issue Stock Acquisition Rights by private placement, payment of the issue price, and partial exercise of the Series 8 Stock Acquisition Rights. - FY2017-Q1RestatedAnnual report
「The company raised ¥800 million through a private placement with a payment date of 9 November 2015, substantially strengthening its financial base.」
The company continues to describe the ¥800 million raised through the private placement as a measure addressing the going-concern issue. - FY2016First statedAnnual report
「The company raised ¥800 million through a private placement with a payment date of 9 November 2015, substantially strengthening its financial base.」
The company raised ¥800 million through a private placement and is strengthening its financial base as part of its response to the going-concern issue.